Company: OXLCZ
Filing Date: 2025-02-21
Form Type: 424B2
Source: 0001213900-25-015823
Chunk: 26

Company: Oxford Lane Capital Corp.
Filing Date: 2025-02-21
Form: 424B2
Chunk 26
---
 offering will be approximately $159,541,750.00 (or approximately $183,518,312.50 if the underwriters fully exercise their over -allotmentoption), in each case assuming a public offering price of 100% of par, after deducting the underwriting discount of $5,156,250.00 (or approximately $5,929,687.50 if the underwriters fully exercise their over -allotmentoption) payable by us and estimated offering expenses of approximately $302,000.00 payable by us. We intend to use the net proceeds from this offering to acquire investments in accordance with our investment objective and strategies described in this prospectus supplement and for general working capital purposes. We anticipate that substantially all of the net proceeds of this offering will be used for the above purposes within approximately three to six months from the consummation of such offering, depending on the availability of appropriate investment opportunities consistent with our investment objective and market conditions. We cannot assure you we will achieve our targeted investment pace. Pending such investments, we will invest the net proceeds primarily in cash, cash equivalents, U.S. government securities and other high -qualityinvestments that mature in one year or less from the date of investment. The management fee payable by us will not be reduced while our assets are invested in such securities. See “Regulation as a Registered Closed -EndManagement Investment Company — Temporary Investments” in the accompanying prospectus for additional information about temporary investments we may make while waiting to make longer -terminvestments in pursuit of our investment objective. S-21 Table of Contents

CAPITALIZATION The following table sets forth our capitalization: (a)on an actual basis as of September 30, 2024; and (b)on an as adjusted basis to reflect the sale of 80,739,195shares of common stock for aggregate net proceeds of $406.5million (of which $405.7million was allocated to capital in excess of par value) from October1, 2024 to February13, 2025 under a common stock at -the-marketoffering; and (c)on an as further adjusted basis to give effect to the offering of $165,000,000 aggregate principal amount of the Notes after deducting underwriting discounts and commissions of $5,156,250 and estimated offering expenses of approximately $302,000. This table should be read in conjunction with “Use of Proceeds” and financial statements and notes thereto included in this prospectus supplement